Recalcitrant Sweet Syndrome successfully treated with adalimumab

J Dtsch Dermatol Ges. 2021 Jan;19(1):122-124. doi: 10.1111/ddg.14223. Epub 2020 Aug 24.

Authors

Laura Calabrese^{1

2}, Giacomo Caldarola^{1

2}, Ketty Peris^{1

2}, Clara De Simone^{1

2}

Affiliations

¹ Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy.
² Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

PMID: 32833303
DOI: 10.1111/ddg.14223

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / therapeutic use
Antibodies, Monoclonal, Humanized
Humans
Sweet Syndrome* / drug therapy
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Adalimumab